AzTrials
AzTrials

Sensorineural Hearing Loss (Disorder)NCT01749592

Single-sided Deafness and Cochlear Implants

A study testing cochlear implant in people with Sensorineural Hearing Loss (Disorder), run by University of Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

As the left and right hemisphere are specialized for different auditory tasks, the proposed study aims at demonstrating different consequences of right or left-sided deafness for the affected individual. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Sensorineural Hearing Loss (Disorder)
What is being tested?
cochlear implant
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteSwitzerland
Study dates
Dec 2012to 8 Feb 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Inclusion criteria: • Patients with acquired single sided sensorineural deafness due to cochlear damage.

  • Age: 18-70 years old.
  • Onset of SSD within 6 months to 10 years before Study inclusion.
  • Normal hearing on the contralateral ear (Hearing thresholds 0.125-2 kHz 25 dB HL or better, 4-8 kHz 35 dB HL or better, 100% speech discrimination at 80 dB SPL).
  • Regular middle ear function on the hearing ear.
  • Regular structure of the cochlea and the cochlear nerve (as demonstrated by MRI, MRI scans are included in the basic assessment of SSD and are no study-specific investigations).
  • Fluency in the German language.
  • Subject is willing to comply with all study requirements.
  • Impairment in daily life as a consequence of SSD (communication problems, annoyance by tinnitus perception).
  • Subject is not participating in another ongoing research study related to the SSD.
  • Subject does not have unrealistic expectations, regarding the outcome of the intervention.
  • Subject has had a trial with conventional acoustic measures in SSD (CROSS, BAHA).

Exclusion criteria: • Uncertainty of correct diagnosis of SSD.

  • Retrocochlear cause of SSD (Deafness due to lesions of the acoustic nerve or central auditory pathways).
  • Active middle ear infections.
  • Ossification of the cochlear that prevents electrode insertion.
  • Tympanic membrane perforation.
  • Psychiatric comorbidities such as depression or cognitive deficits.
  • Severe coexisting illness with a medium survival of less than 5 years.
  • Exposure to radiation with a cumulative effective dose of 5 mSV within the last 5 years (including the ongoing year).
  • Increased risk profile for general anesthesia due to cardiovascular comorbidity.
  • Metallic implants constituting an exclusion criterium for MEG procedures of the brain.
  • Pregnancy (a pregnancy test will be performed in women in the reproductive age group before study enrolment and before postoperative PET scan) and lactation.

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • University Hospital Zurich, Division of Otorhinolaryngology ORL

    Zurich, Canton of Zurich, 8091

Other trials in Switzerland

About this study

Official title: Hemispheric Dominance in Single-sided Postlingual Deafness and Changes / Plasticity Induced by Cochlear Implants

  • As the left and right hemisphere are specialized for different auditory tasks, the proposed study aims at demonstrating different consequences of right or left-sided deafness for the affected individual.
  • Furthermore, the question should be answered if auditory deficits and plastic changes can be partially reversed by cochlear implantation of the deaf ear.
  • Multicenter, prospective, open, non-randomized clinical trial with 5 patients with right-sided and 5 patients with left-sided sensineural deafness.
  • Pre-operative: Audiometry, Sound Localization Audiometry, PET, EEG/MEG
  • Comparison of pre-operative investigations with 10 healthy subjects (age and gender matched control group)
  • Cochlea implantation
  • Follow-up Visits at 3, 6, 9 and 12 month post-operative: Audiometry, Sound Localization Audiometry, PET, EEG, Questionnaires
  • Trial with medical device
Read the detailed description

Postlingual single-sided deafness (SSD) is a type of hearing impairment with normal hearing in one ear and severely impaired hearing in the other ear. The condition induces multiple changes of neural plasticity in central auditory pathways. One manifestation reflects an increased common activation of the contralateral and ipsilateral pathways after stimulation of the normal hearing ear which is correlated with an increased activity between the contralateral and ipsilateral hemispheres. As the left and right hemisphere are specialized for different auditory tasks, the proposed study aims at demonstrating different consequences of right or left-sided deafness for the affected individual. Furthermore, the question should be answered if auditory deficits and plastic changes can be partially reversed by cochlear implantation of the deaf ear. It is assumed that some changes induced by SSD can be detected only by reversal through a cochlear implant.

Being tested
cochlear implant
Keywords
hearing loss, cochlear implant, PET, EEG, MEG
Medical subject headings
Hearing Loss, Sensorineural, Hearing Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cochlear implantDevice

    Surgical implantation of a cochlear implant device

Study groups in NCT01749592
Study groupRoleWhat they receive
Cochlear ImplantExperimentalSurgical Implantation of a Cochlear Implant
Receives: Device: cochlear implant

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Audiometry

    Pure tone audiometry Speech audiometry Sound localization in both quiet and noise

    Measured: up to12 months after invention

Secondary outcomes (1)
  1. PET scan

    [15O] H2O Positron emission tomography (PET) is performed. The comparison of baseline PET scans and stimulated PET scans will demonstrate task related changes in brain activity

    Measured: 9 months after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Dec 2012 (estimated)
  2. Study startDec 2012
  3. Primary completionJan 2018
  4. Study completion8 Feb 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01749592
Sponsor's protocol ID
2012-0034
Status last verified
Sep 2020
First submitted
11 Dec 2012
Last updated
9 Sep 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Peter N, Treyer V, Probst R, Kleinjung T. Auditory Cortical Plasticity in Patients with Single-Sided Deafness Before and After Cochlear Implantation. J Assoc Res Otolaryngol. 2024 Feb;25(1):79-88. doi: 10.1007/s10162-024-00928-3. Epub 2024 Jan 22.

    PubMed 38253897
  • Peter N, Kleinjung T, Probst R, Hemsley C, Veraguth D, Huber A, Caversaccio M, Kompis M, Mantokoudis G, Senn P, Wimmer W. Cochlear implants in single-sided deafness - clinical results of a Swiss multicentre study. Swiss Med Wkly. 2019 Dec 27;149:w20171. doi: 10.4414/smw.2019.20171. eCollection 2019 Dec 16.

    PubMed 31880806

Questions about this trial

What is this clinical trial studying?

A study testing cochlear implant in people with Sensorineural Hearing Loss (Disorder), run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Audiometry (time frame: up to12 months after invention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01749592, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in